Prostate Cancer Clinical Trials in New York

Showing 21-40 of 437 trials

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

NCT07225309

The purpose of this study is to find out if Meaning-Centered Psychotherapy for Latinos (MCP-L) helps reduce anxiety and depression and improves quality of life compared to cognitive behavioral therapy (CBT). Investigators also want to learn what participants and providers think about the therapy, including how the therapy is designed, outside factors, available resources, and how the people involved affect how well MCP-L works.

Breast CancerProstate CancerColorectal Cancer+9 more

Memorial Sloan Kettering Cancer Center300 participantsStarted Jun 2026

New York, New York, United States • Mexico City, Mexico

Active Not RecruitingPhase 1< 1 mile

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

NCT04662580

This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate cancer (mPC).

Metastatic Prostate Cancer

Janssen Research & Development, LLC183 participantsStarted May 2021

La Jolla, California, United States • Los Angeles, California, United States • San Francisco, California, United States +9 more locations

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Prostate Cancer Trials in Other Cities

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Micro-UltraSound In Cancer - Active Surveillance

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Other Conditions in New York